JP2003149204A - Method for separating and identifying hardly soluble protein - Google Patents

Method for separating and identifying hardly soluble protein

Info

Publication number
JP2003149204A
JP2003149204A JP2001351105A JP2001351105A JP2003149204A JP 2003149204 A JP2003149204 A JP 2003149204A JP 2001351105 A JP2001351105 A JP 2001351105A JP 2001351105 A JP2001351105 A JP 2001351105A JP 2003149204 A JP2003149204 A JP 2003149204A
Authority
JP
Japan
Prior art keywords
protein
proteins
identifying
separating
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001351105A
Other languages
Japanese (ja)
Inventor
Keiko Sato
啓子 佐藤
Yoshiya Oda
吉哉 小田
Masanori Tawarada
真紀 俵田
Katsuichi Takeuchi
勝一 竹内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP2001351105A priority Critical patent/JP2003149204A/en
Publication of JP2003149204A publication Critical patent/JP2003149204A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To develop a proteome technique capable of highly sensitively and simply separating and identifying hardly soluble proteins and proteins of large molecular weight. SOLUTION: By performing separation by chromatography instead of two-dimensional electrophoresis, it is possible to separate and identify the hardly soluble proteins and the proteins of large molecular weight which have been difficult by a conventional method.

Description

【発明の詳細な説明】Detailed Description of the Invention

【発明の属する技術的な分野】本発明は、難溶性蛋白質
を分離同定する方法に関する。
TECHNICAL FIELD The present invention relates to a method for separating and identifying a poorly soluble protein.

【従来の技術】ポストゲノム時代をむかえて、生体内の
蛋白質を分離して同定することがますます重要になって
きている。特に受容体などの膜蛋白質の中には、非常に
難溶性の分子が存在することが知られているので、難容
性の分子を効率よく分離し、同定する手段は、創薬や医
学の発展のために有用であると考えられる。なぜなら、
難溶性の蛋白質の中でも膜蛋白質は、創薬のための標的
分子としての可能性や、病気の診断や治療のための標的
分子としての可能性を秘めているからである。同時に多
数の蛋白質を同定する方法としてプロテオーム技術が注
目を集めている。プロテオーム技術は、二次元電気泳動
で分離した各スポットから蛋白質を分解抽出し、質量分
析によりその分子量を測定して、その分子量のフラグメ
ントを生成する可能性のある蛋白質をデータベースから
検索して該蛋白質を同定するという方法である。この方
法は蛋白質を2次元で分離するために、蛋白質の分解能
に優れるが、創薬の標的分子となる可能性の高い難溶性
の蛋白質及び分子量120kDa以上の蛋白質は、1次元目の
ゲルに浸透しないために、難溶性の蛋白質の分離に用い
ることは困難であることが知られている(Rabilloud T.
et al. Electrophoresis 18:307-316 (1997), Oh-Ishi
M. et al. Electrophoresis 21:1653-1669 (200
0))。
2. Description of the Related Art In the post-genome era, it has become more important to separate and identify proteins in the living body. In particular, it is known that there are very sparingly soluble molecules in membrane proteins such as receptors. Therefore, a means for efficiently separating and identifying refractory molecules can be found in drug discovery and medical science. Considered useful for development. Because
This is because, among poorly soluble proteins, membrane proteins have potential as target molecules for drug discovery and as target molecules for diagnosis and treatment of diseases. At the same time, proteome technology has been attracting attention as a method for identifying a large number of proteins. The proteome technique is to decompose and extract a protein from each spot separated by two-dimensional electrophoresis, measure its molecular weight by mass spectrometry, and search the database for a protein that may generate a fragment of that molecular weight, and then search for the protein. Is a method of identifying. Since this method separates proteins in two dimensions, it has excellent protein resolution, but poorly soluble proteins that are likely to be target molecules for drug discovery and proteins with a molecular weight of 120 kDa or more penetrate into the first dimension gel. Therefore, it is known that it is difficult to use for the separation of poorly soluble proteins (Rabilloud T.
et al. Electrophoresis 18: 307-316 (1997), Oh-Ishi
M. et al. Electrophoresis 21: 1653-1669 (200
0)).

【0001】[0001]

【発明が解決しようとする課題】本発明の課題は、難溶
性の蛋白質及び分子量120 kDa以上の蛋白質を感度良く
簡便に分離同定できるプロテオーム技術を開発すること
にある。
SUMMARY OF THE INVENTION An object of the present invention is to develop a proteome technique capable of separating and identifying a poorly soluble protein and a protein having a molecular weight of 120 kDa or more with high sensitivity and in a simple manner.

【0002】[0002]

【課題を解決するための手段】本発明者らは、2次元電
気泳動の最初の工程である等電点電気泳動と比較して、
難溶性蛋白質を分離することが容易であり、分子量の大
きい蛋白質も分離可能なクロマトグラフィー、特にイオ
ン交換クロマトグラフィーによる分離を行い、その後SD
Sポリアクリルアミドゲル電気泳動(SDS-PAGE)による
分離、ゲル内消化と抽出、質量分析を行うことで、従来
の二次元電気泳動を用いた方法では同定ができなかった
不溶性の蛋白質も分離同定できることを見出した。
The present inventors compared with the first step of two-dimensional electrophoresis, isoelectric focusing,
Separation of poorly soluble proteins is easy and separation of proteins with large molecular weight is also possible by chromatography, especially ion exchange chromatography, and then SD
Separation by S polyacrylamide gel electrophoresis (SDS-PAGE), in-gel digestion and extraction, and mass spectrometry can be performed to separate and identify insoluble proteins that could not be identified by conventional methods using two-dimensional electrophoresis. Found.

【0003】すなわち本発明は、 1.以下の工程、 1)蛋白質をクロマトグラフィーにより分離する工程、 2)分離した蛋白質をSDSポリアクリルアミドゲル電気泳
動により分離する工程、 3)分離した蛋白質をゲル内消化し、抽出して質量分析に
より同定する工程から成る、蛋白質を分離同定する方
法。 ここで、蛋白質は特に限定されないが、好ましくは通常
の二次元電気泳動で分離が難しい、難溶性あるいは分子
量の大きい蛋白質である。更に好ましくは、中性界面活
性剤、例えばTriton-X114等により難溶性の蛋白質だけ
を予め分離しておくことが望ましい。また質量分析によ
り同定するとは、蛋白質を分解して得られたオリゴペプ
チドの分子量を質量分析により測定し、その分子量のフ
ラグメントを生成する可能性のある蛋白質をデータベー
スから検索して、該蛋白質を同定することを指す。 2.クロマトグラフィーがイオン交換クロマトグラフィ
ーである、1に記載の方法、に関する。
That is, the present invention is as follows: The following steps, 1) step of separating proteins by chromatography, 2) step of separating separated proteins by SDS polyacrylamide gel electrophoresis, 3) digestion of separated proteins in gel, extraction and identification by mass spectrometry A method for separating and identifying a protein, which comprises the step of: Here, the protein is not particularly limited, but is preferably a protein having a high solubility or a large molecular weight, which is difficult to separate by ordinary two-dimensional electrophoresis. More preferably, it is desirable to preliminarily separate only the sparingly soluble protein with a neutral surfactant such as Triton-X114. Identification by mass spectrometry means that the molecular weight of an oligopeptide obtained by degrading a protein is measured by mass spectrometry, and a protein that may generate a fragment of that molecular weight is searched from a database to identify the protein. It means to do. 2. The method according to 1, wherein the chromatography is ion exchange chromatography.

【0004】[0004]

【発明の実施の形態】本発明は、二次元電気泳動で分離
した各スポットから蛋白質を分解抽出し、質量分析によ
りその分子量を測定して、その分子量のフラグメントを
生成する可能性のある蛋白質をデータベースから検索し
て該蛋白質を同定するというプロテオーム技術を、難溶
性蛋白質・分子量の大きい蛋白質にも適用できるよう改
良したものである。以下に本発明の実施の形態、特に通
常のプロテオーム技術と異なるSDS-PAGEに至る前の工程
について説明する。
BEST MODE FOR CARRYING OUT THE INVENTION According to the present invention, a protein is decomposed and extracted from each spot separated by two-dimensional electrophoresis, and its molecular weight is measured by mass spectrometry. The proteome technique of identifying the protein by searching from a database is improved so that it can be applied to a poorly soluble protein and a protein having a large molecular weight. Hereinafter, embodiments of the present invention, in particular, steps before reaching SDS-PAGE, which is different from ordinary proteome technology, will be described.

【0005】本方法に適用する蛋白質は特に限定されな
いが、好ましくは通常の二次元電気泳動で分離が難し
い、難溶性あるいは分子量の大きい蛋白質である。更に
好ましくは、難溶性の蛋白質、例えば細胞骨格に強く結
合している蛋白質(後シナプス肥厚蛋白質等)を中性界
面活性剤、例えばTriton-X114等により難溶性の蛋白質
だけを予め分離濃縮しておくことが望ましい。具体的に
は難溶性蛋白質は、組織・細胞・細胞画分を0.1〜5%、
好ましくは1〜2%の中性界面活性剤、好ましくはTriton-
X100あるいはTriton-X114を含有する緩衝液中でホモジ
ナイズし遠心分離して不溶性画分として集めることがで
きる。
The protein applied to the present method is not particularly limited, but is preferably a poorly soluble protein having a large molecular weight, which is difficult to separate by ordinary two-dimensional electrophoresis. More preferably, a sparingly soluble protein, for example, a protein strongly bound to the cytoskeleton (postsynaptic thickening protein, etc.) is preliminarily separated and concentrated with a neutral detergent, for example, Triton-X114 etc. It is desirable to set it. Specifically, a poorly soluble protein is a tissue / cell / cell fraction 0.1-5%,
Preferably 1-2% neutral detergent, preferably Triton-
It can be homogenized in a buffer containing X100 or Triton-X114 and centrifuged to collect an insoluble fraction.

【0006】集めた難溶性の蛋白質は、蛋白質を変性さ
せる物質を含む緩衝液、例えば尿素・チオ尿素・塩酸グ
アニジン・イソチオシアン酸カリウム・グアニジンイソ
チオシアネート・ヨウ化カリウム等、次にイオン交換ク
ロマトグラフィーを用いる場合、好ましくは電荷を持た
ない尿素・チオ尿素を含む緩衝液に溶解させる。溶解さ
せた蛋白質は、同様の蛋白質を変性させる物質を含む緩
衝液で平衡化したカラムを用いたクロマトグラフィーに
より分離する。クロマトグラフィーはいかなる原理のク
ロマトグラフィーも許されるが、好ましくは蛋白質を電
気的な性質により分離するイオン交換クロマトグラフィ
ーが望ましい。
The poorly soluble protein collected is subjected to a buffer containing a substance that denatures the protein, such as urea, thiourea, guanidine hydrochloride, potassium isothiocyanate, guanidine isothiocyanate, potassium iodide, and the like, followed by ion exchange chromatography. When used, it is preferably dissolved in a buffer solution containing uncharged urea / thiourea. The dissolved protein is separated by chromatography using a column equilibrated with a buffer containing a substance that denatures the same protein. Chromatography may be any principle of chromatography, but ion exchange chromatography that separates proteins by their electrical properties is preferable.

【0007】分離した蛋白質は、必要であればTCA(三
塩化酢酸)で沈殿させて濃縮し、SDSを含有する緩衝液
に溶解してSDS-PAGE電気泳動により分離する。分離した
後は、通常のプロテオーム技術に準じて、ゲル内消化・
抽出・質量分析を行うことができる(Oda Y. et al. Na
t. Biotechnol. 19:379-382 (2001))。
If necessary, the separated protein is precipitated with TCA (trichloroacetic acid), concentrated, dissolved in a buffer containing SDS, and separated by SDS-PAGE electrophoresis. After separation, in accordance with normal proteome technology, in-gel digestion and
Extraction and mass spectrometry can be performed (Oda Y. et al. Na
t. Biotechnol. 19: 379-382 (2001)).

【0008】[0008]

【発明の効果】本発明により、従来の方法では困難であ
った難溶性の蛋白質及び分子量の大きい蛋白質の分離同
定が簡便に行えるようになった。
Industrial Applicability According to the present invention, it becomes possible to easily separate and identify a poorly soluble protein and a protein having a large molecular weight, which were difficult by the conventional methods.

【0009】[0009]

【実施例】以下に、具体的な例をもって本発明を示す
が、本発明はこれに限られるものではない。 [実施例1]後シナプス肥厚(PSD)分画のTriton-X114
不溶性分画の蛋白質の分離同定 1)Triton-X114不溶性分画の調製 8週齢のマウス、Balb/c、48匹の脳から竹内ら(Takeuch
i M. et al. J. Biol.Chem. 272:11943-11951 (1997))
の方法によりPSD分画を精製した。得られたPSD分画(総
蛋白質量19.4 mg)を蛋白質濃度1 mg/mlになるように緩
衝液A(20 mMTris/Cl pH 7.4, 100 mM NaCl, 2 mM EDT
A, 1 mM DTT, 2% Triron-X114)にホモジナイズした
後、4度にて15分間撹拌した。その後、196,000 xgで30
分遠心し、得られた沈澱をTriton-X114不溶性分画とし
てした。 2)イオン交換クロマトグラフィーによる分離 Triton-X114不溶性分画(総蛋白質量8.35 mg)を緩衝液
B(20 mM Hepes pH 7.5, 7 M Urea, 2 M Thiourea, 0.
9% CHAPS, 10mM DTT)8 mlにけん濁して、10,000 xgで1
0分間遠心し、上清に希釈緩衝液(20 mM Hepes pH 7.5,
1 mM DTT)を4ml加えた後に、再び10,000 xgで10分間遠
心した上清をイオン交換クロマトグラフィーに供した。
平衡化緩衝液(20 mM Hepes pH 7.5, 6 M Urea, 0.6% C
HAPS, 1 mM DTT)で平衡化したMonoQ 5/5カラム(アマ
シャムファルマシア社)にサンプルをアプライした後
に、NaCl濃度1Mまでの濃度勾配により溶出した。溶出さ
れた各フラクションの一部を10%ポリアクリルアミドゲ
ルによるSDS-PAGEで分離後、銀染色を行った像を図1に
示した。 3)フラクション17から24の質量分析法による蛋白質の同
定 得られたフラクションのうち、抗体による検索で後シナ
プス肥厚蛋白質を多く含んでいた17から24までの画分
を、TCA沈澱により濃縮した後に、10%ポリアクリルアミ
ドゲルのSDS-PAGEにより分離した。Zincステインキット
(バイオラッド)を用いて、ネガテイブ染色を行った後
に、蛋白質のバンドを65個に分割した。切り出したゲル
は、小田ら(Oda Y. et al. Nat. Biotechnol. 19:379-
382 (2001))の方法により、ゲル内消化と質量分析法の
よる蛋白質の同定を行った。同定蛋白質のリストを表1
に示した。
EXAMPLES The present invention will be described below with reference to specific examples, but the present invention is not limited thereto. [Example 1] Post-synaptic thickening (PSD) fraction of Triton-X114
Isolation and identification of proteins in the insoluble fraction 1) Preparation of Triton-X114 insoluble fraction Taken et al. (Takeuch et al.
i M. et al. J. Biol. Chem. 272: 11943-11951 (1997))
The PSD fraction was purified by the method described in 1. The resulting PSD fraction (total protein mass 19.4 mg) was adjusted to a protein concentration of 1 mg / ml with buffer A (20 mM Tris / Cl pH 7.4, 100 mM NaCl, 2 mM EDT).
A, 1 mM DTT, 2% Triron-X114) was homogenized and then stirred at 4 degrees for 15 minutes. Then 30 at 196,000 xg
Centrifugation was performed, and the resulting precipitate was used as a Triton-X114 insoluble fraction. 2) Separation by ion exchange chromatography Triton-X114 insoluble fraction (total protein mass 8.35 mg) was added to buffer B (20 mM Hepes pH 7.5, 7 M Urea, 2 M Thiourea, 0.
9% CHAPS, 10mM DTT) Suspended in 8 ml, 1 at 10,000 xg
Centrifuge for 0 minutes and add the dilution buffer (20 mM Hepes pH 7.5,
After adding 4 ml of 1 mM DTT), the supernatant was centrifuged again at 10,000 xg for 10 minutes and subjected to ion exchange chromatography.
Equilibration buffer (20 mM Hepes pH 7.5, 6 M Urea, 0.6% C
After applying the sample to a MonoQ 5/5 column (Amersham Pharmacia) equilibrated with HAPS, 1 mM DTT), the sample was eluted with a concentration gradient up to a NaCl concentration of 1 M. A part of the eluted fractions was separated by SDS-PAGE on a 10% polyacrylamide gel and then stained with silver. The image is shown in FIG. 3) Identification of proteins by mass spectrometry of fractions 17 to 24 Of the obtained fractions, the fractions 17 to 24, which contained a large amount of post-synaptic thickening protein in the antibody search, were concentrated by TCA precipitation, Separation by SDS-PAGE on 10% polyacrylamide gel. After negative staining was performed using Zinc stain kit (Bio-Rad), the protein band was divided into 65 bands. The excised gel was prepared by Oda et al. (Oda Y. et al. Nat. Biotechnol. 19: 379-
382 (2001)), the protein was identified by in-gel digestion and mass spectrometry. Table 1 for a list of identified proteins
It was shown to.

【表1】 4) 同定蛋白質について すでにPSDに存在していることが明らかになっている細
胞骨格系、スカフォールド分子、膜蛋白質を同定するこ
とができた。従来の方法であるPSD分画をそのままSDS-P
AGEにより分離して質量分析法により同定する方法(Wal
ikonis RS. etal. J. Neurosci. 20:4069-4080 (200
0))では、同定できなかった難溶性分子のSAPAP(Hirao
K. et al. Genes Cells 5:203-210 (2000))を同定で
きた。また、一般的に難溶性であると考えられているDe
nsin-180などの膜蛋白質も同定することができた。以上
のことから、本方法は、これまでは検出できなかった難
溶性分子を同定可能な手段であると考えられた。
[Table 1] 4) Identified proteins We were able to identify cytoskeletal systems, scaffold molecules, and membrane proteins that were already known to exist in PSD. The PSD method that is the conventional method is used as is for SDS-P
Method to separate by AGE and identify by mass spectrometry (Wal
ikonis RS. et al. J. Neurosci. 20: 4069-4080 (200
0)), SAPAP (Hirao
K. et al. Genes Cells 5: 203-210 (2000)) could be identified. In addition, De, which is generally considered to be insoluble,
Membrane proteins such as nsin-180 could also be identified. Based on the above, this method was considered to be a means for identifying poorly soluble molecules that could not be detected up to now.

【0010】[0010]

【図面の簡単な説明】[Brief description of drawings]

【図1】後シナプス肥厚分画をイオン交換クロマトグラ
フィーで分離した各フラクションのSDS-PAGE。
FIG. 1: SDS-PAGE of each fraction obtained by separating the post-synaptic thickening fraction by ion exchange chromatography.

フロントページの続き (72)発明者 竹内 勝一 京都市下京区西七条石井町3317シャローム 33 202号 Fターム(参考) 2G052 AB18 AD29 AD46 CA03 CA04 ED04 ED07 GA22 GA24 Continued front page    (72) Inventor Shoichi Takeuchi             3317 Shalom, Nishi Shichijo Ishiimachi, Shimogyo-ku, Kyoto-shi             No. 33 202 F-term (reference) 2G052 AB18 AD29 AD46 CA03 CA04                       ED04 ED07 GA22 GA24

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】以下の工程、 1)蛋白質をクロマトグラフィーにより分離する工程、 2)分離した蛋白質をSDSポリアクリルアミドゲル電気泳
動により分離する工程、 3)分離した蛋白質をゲル内消化し、抽出して質量分析に
より同定する工程から成る、蛋白質を分離同定する方
法。
1. The following steps, 1) a step of separating proteins by chromatography, 2) a step of separating separated proteins by SDS polyacrylamide gel electrophoresis, 3) digestion of the separated proteins in a gel and extraction. A method for separating and identifying proteins, which comprises the step of identifying by means of mass spectrometry.
【請求項2】クロマトグラフィーがイオン交換クロマト
グラフィーである、請求項1に記載の方法。
2. The method of claim 1, wherein the chromatography is ion exchange chromatography.
JP2001351105A 2001-11-16 2001-11-16 Method for separating and identifying hardly soluble protein Pending JP2003149204A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001351105A JP2003149204A (en) 2001-11-16 2001-11-16 Method for separating and identifying hardly soluble protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001351105A JP2003149204A (en) 2001-11-16 2001-11-16 Method for separating and identifying hardly soluble protein

Publications (1)

Publication Number Publication Date
JP2003149204A true JP2003149204A (en) 2003-05-21

Family

ID=19163470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001351105A Pending JP2003149204A (en) 2001-11-16 2001-11-16 Method for separating and identifying hardly soluble protein

Country Status (1)

Country Link
JP (1) JP2003149204A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020622A1 (en) * 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020622A1 (en) * 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis

Similar Documents

Publication Publication Date Title
Rogers et al. Proteolytic post-translational modification of proteins: proteomic tools and methodology
Cleland et al. Mass spectrometry and antibody-based characterization of blood vessels from Brachylophosaurus canadensis
D'Amato et al. In-depth exploration of Hevea brasiliensis latex proteome and “hidden allergens” via combinatorial peptide ligand libraries
Teerasak et al. Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions
Lu et al. Strategies for shotgun identification of integral membrane proteins by tandem mass spectrometry
Pitarch et al. Analysis of the Candida albicans proteome: I. strategies and applications
JP2002534681A (en) Method and kit for extracting prion protein
Wang et al. Proteomic identification of potential Clonorchis sinensis excretory/secretory products capable of binding and activating human hepatic stellate cells
Gross et al. Tissue fractionation by hydrostatic pressure cycling technology: the unified sample preparation technique for systems biology studies
JP4571228B2 (en) Method for concentrating low molecular weight proteins and peptides in body fluid samples
Verma et al. Identification of proteins secreted by malaria parasite into erythrocyte using SVM and PSSM profiles
Coiras et al. Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents
Scumaci et al. Assessment of an ad hoc procedure for isolation and characterization of human albuminome
JP3822454B2 (en) Method for identifying phosphorylated protein
García Two-dimensional gel electrophoresis in platelet proteomics research
JP2003149204A (en) Method for separating and identifying hardly soluble protein
Kline et al. MudPIT analysis: application to human heart tissue
KR101579946B1 (en) Method and Kit for Isolating and Fractioning Phosphoproteins
Caumo et al. Proteomic profiling of the infective trophozoite stage of Acanthamoeba polyphaga
Cordwell Acquisition and archiving of information for bacterial proteomics: from sample preparation to database
Zhou et al. Proteomic analysis by two-dimensional polyacrylamide gel electrophoresis
Bousquet-Dubouch et al. Purification and proteomic analysis of 20S proteasomes from human cells
Mottaz-Brewer et al. Optimization of proteomic sample preparation procedures for comprehensive protein characterization of pathogenic systems
Butorac et al. Benefits of selective peptide derivatization with sulfonating reagent at acidic pH for facile matrix‐assisted laser desorption/ionization de novo sequencing
Joss et al. Evaluation of chemical derivatisation methods for protein identification using MALDI MS/MS

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051027

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051209

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060623

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20060703

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061018